Drug Shortage Report for LABETALOL HYDROCHLORIDE INJECTION USP
| Report ID | 89343 |
| Drug Identification Number | 02391090 |
| Brand name | LABETALOL HYDROCHLORIDE INJECTION USP |
| Common or Proper name | Labetalol |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | LABETALOL HYDROCHLORIDE |
| Strength(s) | 5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 50x1mL Amp |
| ATC code | C07AG |
| ATC description | BETA BLOCKING AGENTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2019-07-15 |
| Estimated end date | |
| Actual end date | 2019-08-27 |
| Shortage status | Resolved |
| Updated date | 2019-08-28 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2019-08-28 | French | Compare |
| v4 | 2019-08-28 | English | Compare |
| v3 | 2019-07-16 | English | Compare |
| v2 | 2019-07-15 | French | Compare |
| v1 | 2019-07-15 | English | Compare |
Showing 1 to 5 of 5